Exosomes are nano-sized vesicles that serve as mediators for cell-to-cell communication. investigate therapeutic potential of MSC-exosomes and relevant mode of actions for skin diseases, as well as quality control measures required for development of exosome-derived therapeutics. Reduced BPD through macrophage M22 polarization[86]Human umbilical cord (UC)-MSCsExosomesUltracentrifugationlet-7bTLR4, p-p65, iNOS Reduced IBD by polarizing M2 macrophage in mice[92]Rat ASCsExosomesUltracentrifugation-S1P, SphK1, S1PR1 (CD86+/CD206+ cells)[20,109]Renal injuryRat BM-MSCsExosomesUltracentrifugation-MDA, HIF1, NOX2, Caspase 3, BAX, PARP1, MPO, ICAM1, IL-1, NF-B in aged mice Chenodeoxycholic acid [202]. Another report revealed that EVs derived from serum of young mice attenuated inflammaging in old mice by partially rejuvenating aged T-cell immunotolerance [203]. Implantation of hypothalamic stem/progenitor cells, which were genetically engineered to survive from aging-related hypothalamic inflammation, was reported to induce retardation of aging and extension of lifespan in mid-aged mice [204]. More importantly, growing evidence suggests that cellular senescence can be alleviated or reversed by EVs or exosomes derived from stem cells (Table 4) [205,206,207,208,209,210,211,212,213,214]. Human ASC-exosomes reduced the high glucose-induced premature senescence of endothelial progenitor cells (EPCs) and enhanced wound healing in diabetic rats [205]. In the same study, overexpression of nuclear factor erythroid 2-related factor 2 (NRF2) in human ASC-exosomes Chenodeoxycholic acid further reduced premature senescence of EPCs, and promoted wound healing in diabetic rats by modulating the expression of various proteins [205]. Since high glucose in diabetics induces reactive air varieties (ROS) and swelling, which promotes impairs and senescence function of EPCs, decreased senescence of EPCs by ASC-exosomes may be beneficial for the treating diabetic base ulcers [205]. It has additionally been reported that human being ASC-exosomes consist of lnRNA MALAT1 and recover function of engine behavior with reduced amount of cortical mind damage inside a rat distressing mind damage model [142]. Concerning this, a report revealed how the MALAT1 manifestation is low in aged mice which treatment of human being UC-MSC-exosomes including MALAT1 prevents ageing in D-galactose (gal)-treated mice and senescence in H2O2-treated H9C2 cardiomyocytes [206]. MALAT1 is among the applicants for anti-aging results in stem cell-derived exosomes, since MALAT1-knockdown in UC-MSCs abolished these ramifications of UM-MSC-exosomes. Likewise, exosomal miR-146a was recognized to regulate senescence of MSCs by targeting the NF-mRNA negatively. As a total result, the known degree of NRF2, a get better at regulator of anti-oxidative reactions [217], was Chenodeoxycholic acid risen to induce the manifestation of its downstream focuses on such as for example heme oxygenase 1 (HO1), superoxide dismutase (SOD), and catalase (Kitty) [213]. ESC-exosomes advertised pressure ulcer curing in D-gal-induced aged mice by reducing endothelial Chenodeoxycholic acid senescence and raising angiogenesis [212]. Human being iPSC-exosomes had been reported to safeguard HDFs from UVB damage, reduce the senescence-associated MMP-1/3 expression, and induce synthesis of collagen type I in both UVB-damaged and senescent HDFs [214]. Human iPSC-exosomes were also reported to reduce SA–gal and increase cell viability and tube formation of high glucose-injured HUVECs with unknown mechanism [214]. Exosomes from various cells are also useful as a delivery vehicle of biomolecules to suppress senescence. The miR-675 was discovered as a candidate marker for aging [207]. Delivery of miR-675 through UC-MSC-exosomes reduced the SA–gal expression, and the levels of p21 and TGF-1 proteins in H2O2-induced senescent H9C2 cells by targeted downregulation of TGF-1. Additionally, miR-675-UC-MCS- exosomes promoted perfusion in ischemic hindlimb by inhibiting the expression of both mRNAs and proteins of p21 and TGF-1 [207]. Another study reported that exosomes derived from Wnt4-overexpressed mouse thymic epithelial cells (TECs) inhibited dexamethasone-induced aging phenotypes in TECs [218]. Taken together, MSC-exosomes confer anti-senescence effects through their unique miRNA, lnRNA, and enzyme contents. By inducing proliferation and reducing SASP in senescent cells, they hold great potential to reduce senescent cells in tissues. Since removal of senescent cells from tissues was reported to create a pro-regenerative environment [168] and tissue homeostasis [166], application of MSC-exosomes to remove ARMD10 the senescent cells may be a preferable approach to induce the regeneration or rejuvenation of tissues. 6. Cutaneous Wound Healing by MSC-Exosomes A wound is a type of injury in skin. An open wound is caused by a tear, cut, or puncture, and a closed wound is caused by blunt trauma [219]. Cutaneous wounds can be classified into acute and chronic wounds [220]. Acute wounds are highly prevalent from a loss of dermis and epidermis caused by mechanical, chemical, Chenodeoxycholic acid biological, or thermal injuries. Chronic wounds, on the other hand, are common comorbidities of complex diseases such as obesity, diabetes, and vascular disorders. Four categories of chronic wounds include pressure ulcers, diabetic ulcers, venous ulcers, and arterial insufficiency ulcers according to the Wound Healing Society [221]. Since chronic wounds do not heal.
Categories